Atlas Trials

Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma

Clinical trial NCT02302495 · COMPLETED

Trial details

NCT number
NCT02302495
Sponsor
University Hospital, Lille
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2014-01-08
Primary completion
2016-07-17
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.